NL8302709A - HAIR REGROWTH. - Google Patents
HAIR REGROWTH. Download PDFInfo
- Publication number
- NL8302709A NL8302709A NL8302709A NL8302709A NL8302709A NL 8302709 A NL8302709 A NL 8302709A NL 8302709 A NL8302709 A NL 8302709A NL 8302709 A NL8302709 A NL 8302709A NL 8302709 A NL8302709 A NL 8302709A
- Authority
- NL
- Netherlands
- Prior art keywords
- hair growth
- hair
- placenta
- year
- subject
- Prior art date
Links
- 230000003659 hair regrowth Effects 0.000 title description 2
- 230000003779 hair growth Effects 0.000 claims description 20
- 238000012360 testing method Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 10
- 210000004907 gland Anatomy 0.000 claims description 9
- 210000002826 placenta Anatomy 0.000 claims description 8
- 210000001550 testis Anatomy 0.000 claims description 5
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 4
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 4
- 241000283707 Capra Species 0.000 claims description 4
- 235000014121 butter Nutrition 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- 239000006286 aqueous extract Substances 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000000265 homogenisation Methods 0.000 claims 1
- 210000004209 hair Anatomy 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 8
- 210000004761 scalp Anatomy 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000220645 Leonotis nepetifolia Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- -1 Parahydroxybenzoic acid methyl ester Chemical class 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Birds (AREA)
- Reproductive Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Moulding By Coating Moulds (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
Description
« β «é-\ t "a VO 4973 H&argro eimidde1«Β« é- \ t "a VO 4973 H & argro eimidde1
De uitvinding betreft een haargroeimiddel.The invention relates to a hair growth agent.
Tot dusver werden haargroeimiddelen met de meest verschillende samenstellingen voorgesteld. Geen van deze middelen levert echter een bevredigende bevordering van de haargroei op. In de medische vak-5 wereld heerst daarom de mening, dat er geen effectief haargroeimiddel zou bestaan. De uitvinding betreft echter een middel, waarmee de haar-’ groei op de menselijke hoofdhuid kan worden bevorderd en eventueel opnieuw in gang kan worden gezet.So far, hair growth agents with the most different compositions have been proposed. However, neither of these remedies satisfactorily promotes hair growth. The medical profession therefore believes that there is no effective hair growth product. The invention, however, relates to a means by which hair growth on the human scalp can be promoted and possibly restarted.
Dit wordt bereikt door een haargroeimiddel, dat geiteboter als-10 mede kliermateriaal-uit testes en placenta bevat.This is accomplished by a hair growth agent, which contains goat butter as well as glandular material from testes and placenta.
' Het kliermateriaal stamt onder meer op grond van de gemakkelijke toegankelijkheid bij voorkeur van het rund. Men kan echter ook testes en placenta van andere zoogdieren gebruiken.The gland material originates, inter alia, due to the easy accessibility, preferably of the bovine. However, one can also use testes and placenta from other mammals.
Als kliermateriaal is een produkt geschikt, dat door homogeni-15 seren en lyofiliseren van verse klieren is verkregen. Bij voorkeur worden zogenaamde waterige extracten uit testes en placenta gebruikt, die bijvoorbeeld in een verse klierzalf vervat zijn, die onder de handelsnaam "tactu-nerval" van Feldhoff te Senden in de handel is.As a gland material is suitable a product obtained by homogenizing and lyophilizing fresh glands. So-called aqueous extracts from testes and placenta are preferably used, which are, for example, contained in a fresh gland ointment, which is commercially available under the trade name "tactu-nerval" from Feldhoff in Senden.
Het placentamateriaal is bij voorkeur oestrogeenvrij.The placenta material is preferably estrogen-free.
20 Bovendien kan het onderhavige haargroeimiddel ook nog berkensap bevatten. Gunstig is voorts ook een toeslag van etherische oliën, bijvoorbeeld olium juniperi, lauri, rosmarini, terebinthinae, thymi en dergelijke.In addition, the present hair growth agent may also contain birch sap. Also advantageous is an addition of essential oils, for example olium juniperi, lauri, rosmarini, terebinthinae, thymi and the like.
Het onderhavige haargroeimiddel wordt bij voorkeur in de vorm * 25 van een zalf of tinctuur geprepareerd. Hiervoor worden in de farma- f ceutische praktijk gebruikelijke bases toegepast. Het percentage van een dergelijke basis kan ca. 20-60 gew.% bedragen.The present hair growth agent is preferably formulated in the form of an ointment or tincture. Conventional bases are used for this in pharmaceutical practice. The percentage of such a base can be about 20-60% by weight.
De overige bestanddelen zijn bij voorkeur in de volgende hoeveelheden aanwezigs geiteboter 2-15, liefst 5-10%, testesmateriaal 2-10, 30 liefst 5-7 gew.%, placentamateriaal 0,5-5, liefst 1-3 gew.%, berkensap 0-30, liefst 10-20 gew.%, ethanol 0-40, liefst 20-30 gew.%, en etherische oliën 0-10, liefst 2-6 gew.%.The other ingredients are preferably present in the following amounts of goat butter 2-15, most preferably 5-10%, testes material 2-10, most preferably 5-7 wt%, placenta material 0.5-5, most preferably 1-3 wt% birch sap 0-30, preferably 10-20 wt%, ethanol 0-40, most preferably 20-30 wt%, and essential oils 0-10, most preferably 2-6 wt%.
Voorts kan het onderhavige haargroeimiddel bovendien in de farmacologische praktijk gebruikelijke bestanddelen, bijvoorbeeld 35 verdunningsmiddelen en conserveermiddelen bevatten. Als conserveer- --- 8302709 *1 -2- middel is parahydroxybenzoëzuurmethylester bijzonder geschikt.Furthermore, the present hair growth agent may additionally contain ingredients which are customary in pharmacological practice, for example diluents and preservatives. Parahydroxybenzoic acid methyl ester is particularly suitable as a preservative.
De toepassing van het onderhavige haargroeimiddel vindt bij voorkeur als volgt plaats: De hoofdhuid wordt eerst ca. 15 minuten droog met een haarborstel gemasseerd. Vervolgens wordt het preparaat 5 .dun op de hoofdhuid aangebracht en ca. 2-5 minuten met de vingertoppen ingewreven. Gedurende de hierop volgende 3 uren moet de hoofdhuid liever niet worden afgewassen. Dit proces vindt eenmaal daags plaats.The application of the present hair growth agent preferably takes place as follows: The scalp is first massaged dry with a hair brush for about 15 minutes. The preparation is then applied thinly to the scalp and rubbed with the fingertips for approx. 2-5 minutes. During the next 3 hours, the scalp should preferably not be washed off. This process takes place once a day.
De behandelingsduur bedraagt over het algemeen 4 weken. Aan-10 sluitend daaraan kan een ondersteunende verdere behandeling één tot tweemaal per week maximaal 1 half jaar lang worden uitgevoerd. Het volgende voorbeeld en een beschrijving van praktijkproeven lichten de uitvinding nader toe.The duration of treatment is generally 4 weeks. Subsequently, supportive further treatment can be carried out once or twice a week for up to 1 half year. The following example and a description of field tests further illustrate the invention.
Voorbeeld 15 Uit de volgende bestanddelen werd een zalf bereid:Example 15 An ointment was prepared from the following ingredients:
Bestanddeel gComponent g
Geiteboter 7,5Goat butter 7.5
Testesextract (rund) aquos. 1,14:1 6Testesis extract (bovine) aquos. 1.14: 1 6
Oestrogeenvrij placenta-extract 20 (rund) aquos. 1,15:1 2Estrogen-free placenta extract 20 (bovine) aquos. 1.15: 1 2
Berkensap 15Birch sap 15
Ethanol 30Ethanol 30
Etherische oliën 3,5Essential oils 3.5
Zalf-/tinctuurbas is ad 100 25 Proeven 1. ProefpersoonOintment / tincture bass is ad 100 25 Tests 1. Test subject
Een 17-jarige mannelijke proefpersoon die sinds 1 jaar kaalhoofdig was, werd dagelijks met het onderhavige haargroeimiddel behandeld. Na 10 dagen waren de eerste aanwijzingen omtrent een nieuwe t 30 beharing zichtbaar; na ca. 10 weken was de gehele haarbodem met haren van 2,5-3 cm lengte bedekt.A 17-year-old male subject who had been bald-headed for 1 year was treated daily with the subject hair growth product. After 10 days, the first indications of a new t 30 hair were visible; after about 10 weeks, the entire base of the hair was covered with hairs of 2.5-3 cm length.
2. Proefpersoon2. Test subject
Een 30-jarige man met een gedeeltelijk kaal hoofd nam de behandeling op, toen ook de zijwaartse restharen begonnen uit te vallen.A 30-year-old man with a partially bald head took up treatment when the sideways residual hair also started to fall out.
8302709 -3-8302709 -3-
Na 4 dagen kwam de haaruitval tot stilstand en na 10 dagen groeiden nieuwe haren.After 4 days the hair loss came to a halt and after 10 days new hairs grew.
3. Proefpersoon3. Test subject
Een 32-jarige mannelijke proefpersoon die gedeeltelijk kaal 5 was werd als de tweede proefpersoon behandeld. Het succes was gelijk als bij de tweede proefpersoon.A 32-year-old male subject who was partially bald 5 was treated as the second subject. The success was the same as for the second subject.
4. Proefpersoon4. Test subject
Bij een 36-jarige man die gedeeltelijk kaal was trad na 30 dagen behandelen een hernieuwde haargroei op met een haarlengte van 1,5-2 cm. 10 5. ProefpersoonIn a 36-year-old man who was partially bald, after 30 days of treatment, hair regrowth occurred with a hair length of 1.5-2 cm. 10 5. Test subject
Een 27-jarige man-die gedeeltelijk kaal was verkreeg na een behandeling van 4 weken zijn volle beharing terug met een haarlengte tot 2 cm.A 27-year-old man, who was partially bald, regained full hair with a hair length of up to 2 cm after 4 weeks of treatment.
6. Proefpersoon 15 Een 50-jarige vrouw met vrij grote kale plekken werd met het onderhavige middel behandeld. Na 9 dagen kreeg men de eerste aanwijzing omtrent haargroei. Na 4 weken was het hoofdhaar volledig geregenereerd.6. Subject 15 A 50-year-old woman with fairly large bald patches was treated with the present product. After 9 days they received the first indication of hair growth. After 4 weeks, the hair on the head was completely regenerated.
7. Proefpersoon 20 Bij een 55-jarige vrouw was het hoofdhaar plaatselijk volledig uitgevallen. Zij kreeg dezelfde behandeling als de zesde proefpersoon, waarbij hetzelfde succes werd bereikt.7. Test subject 20 In a 55-year-old woman, the hair on the head was completely lost locally. She received the same treatment as the sixth subject, achieving the same success.
Afgezien van hoofdhaar kan met onderhavige haargroeimiddel ook de groei van wenkbrauwen worden geregenereerd.In addition to scalp hair, eyebrow growth can also be regenerated with the present hair growth product.
25 De genoemde proeven werden gedeeltelijk door medische controle- onderzoekingen begeleid, waarbij geen enkele nevenwerking of verandering, speciaal wat betreft het bloedbeeld werd waargenomen. Een toepassing van dit sterk werkzame haargroeimiddel lijkt daarmede zonder enig bezwaar.The said tests were partially supervised by medical examinations, no side effects or changes, especially in the blood count, were observed. An application of this highly effective hair growth agent thus seems without any objection.
83027098302709
Claims (6)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3228486A DE3228486C2 (en) | 1982-07-30 | 1982-07-30 | Hair restorer |
| DE3228486 | 1982-07-30 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8302709A true NL8302709A (en) | 1984-02-16 |
| NL192916B NL192916B (en) | 1998-01-05 |
| NL192916C NL192916C (en) | 1998-05-07 |
Family
ID=6169712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8302709A NL192916C (en) | 1982-07-30 | 1983-07-29 | Hair care product. |
Country Status (34)
| Country | Link |
|---|---|
| JP (1) | JPS5929610A (en) |
| KR (1) | KR840005344A (en) |
| AR (1) | AR231071A1 (en) |
| AT (1) | AT391268B (en) |
| AU (1) | AU566726B2 (en) |
| BE (1) | BE897348A (en) |
| BR (1) | BR8304010A (en) |
| CA (1) | CA1203753A (en) |
| CH (1) | CH653548A5 (en) |
| CS (1) | CS244941B2 (en) |
| DD (1) | DD209969A5 (en) |
| DE (1) | DE3228486C2 (en) |
| DK (1) | DK161867C (en) |
| EG (1) | EG15967A (en) |
| FI (1) | FI79466C (en) |
| FR (1) | FR2530952B1 (en) |
| GB (1) | GB2124903B (en) |
| GR (1) | GR79344B (en) |
| HU (1) | HU194731B (en) |
| IE (1) | IE55583B1 (en) |
| IL (1) | IL69281A0 (en) |
| IN (1) | IN156679B (en) |
| IT (1) | IT1195707B (en) |
| LU (1) | LU84918A1 (en) |
| MA (1) | MA19854A1 (en) |
| NL (1) | NL192916C (en) |
| NO (1) | NO162365B (en) |
| NZ (1) | NZ205084A (en) |
| PH (1) | PH17432A (en) |
| PL (1) | PL243227A1 (en) |
| PT (1) | PT77129B (en) |
| RO (1) | RO88665A (en) |
| SE (1) | SE8303998L (en) |
| ZA (1) | ZA835175B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6328627A (en) * | 1986-07-22 | 1988-02-06 | Toyobo Co Ltd | Orientated polyester film |
| JPH01263025A (en) * | 1988-04-14 | 1989-10-19 | Toyobo Co Ltd | Biaxially oriented polyester film |
| JPH02129230A (en) * | 1988-11-08 | 1990-05-17 | Diafoil Co Ltd | Oriented polyester film |
| US5116607A (en) * | 1990-02-27 | 1992-05-26 | Jones Alma L | Hair dressing |
| EP0606039A1 (en) * | 1993-01-08 | 1994-07-13 | Adrien Guy Perez | Composition containing plant saps and plant extracts |
| KR20020049249A (en) * | 2000-12-19 | 2002-06-26 | 박동기 | Composition for stimulating/inducing hair growth and process for their preparation |
| FR3057165B1 (en) * | 2016-10-06 | 2019-06-28 | Gabriela Haias | NOVEL USE OF VINEYARDS FOR THE PREPARATION OF COSMETIC COMPOSITIONS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH40832A (en) * | 1908-02-13 | 1908-08-17 | Ignaz Leutner | Hair growth promoters |
| FR936084A (en) * | 1946-10-26 | 1948-07-08 | Product for the maintenance and beautification of the hair | |
| FR1024740A (en) * | 1950-09-20 | 1953-04-07 | Rinis | Process for preparing a hair lotion and new product resulting therefrom |
| FR1034996A (en) * | 1951-04-03 | 1953-08-10 | Penetrating and nourishing beauty cream | |
| IT941999B (en) * | 1964-04-22 | 1973-03-10 | Prehar Sa | PREPARED FOR CAL VIZIE CARE |
| DE1617857C3 (en) * | 1967-05-24 | 1980-03-13 | Struthers Scientific And International Corp., New York, N.Y. (V.St.A.) | Cosmetic preparation for the treatment of the human scalp |
| GB1385318A (en) * | 1971-01-29 | 1975-02-26 | Mediline Ag | Toiletry preparation for their hair |
| FR2299019A1 (en) * | 1975-01-30 | 1976-08-27 | Vibert Ets F | Capillary lotion used as hair conditioner - contg. human placenta extract and a quaternary resin |
| DE2540971A1 (en) * | 1975-09-13 | 1977-03-17 | Hoechst Ag | HAIR GROWTH PRODUCTS |
-
1982
- 1982-07-30 DE DE3228486A patent/DE3228486C2/en not_active Expired - Fee Related
-
1983
- 1983-07-05 CH CH3685/83A patent/CH653548A5/en not_active IP Right Cessation
- 1983-07-06 GR GR71877A patent/GR79344B/el unknown
- 1983-07-08 CS CS835204A patent/CS244941B2/en unknown
- 1983-07-11 PH PH29197A patent/PH17432A/en unknown
- 1983-07-12 AU AU16742/83A patent/AU566726B2/en not_active Ceased
- 1983-07-13 AR AR293600A patent/AR231071A1/en active
- 1983-07-14 AT AT0259283A patent/AT391268B/en not_active IP Right Cessation
- 1983-07-15 SE SE8303998A patent/SE8303998L/en unknown
- 1983-07-15 ZA ZA835175A patent/ZA835175B/en unknown
- 1983-07-15 LU LU84918A patent/LU84918A1/en unknown
- 1983-07-16 IN IN890/CAL/83A patent/IN156679B/en unknown
- 1983-07-20 IL IL69281A patent/IL69281A0/en unknown
- 1983-07-20 BE BE6/47855A patent/BE897348A/en not_active IP Right Cessation
- 1983-07-20 JP JP58131088A patent/JPS5929610A/en active Pending
- 1983-07-20 EG EG439/83A patent/EG15967A/en active
- 1983-07-21 FR FR8312092A patent/FR2530952B1/en not_active Expired
- 1983-07-25 MA MA20075A patent/MA19854A1/en unknown
- 1983-07-26 RO RO83111737A patent/RO88665A/en unknown
- 1983-07-26 IT IT85604/83A patent/IT1195707B/en active
- 1983-07-27 CA CA000433293A patent/CA1203753A/en not_active Expired
- 1983-07-27 FI FI832711A patent/FI79466C/en not_active IP Right Cessation
- 1983-07-27 IE IE1766/83A patent/IE55583B1/en not_active IP Right Cessation
- 1983-07-27 BR BR8304010A patent/BR8304010A/en unknown
- 1983-07-28 GB GB08320359A patent/GB2124903B/en not_active Expired
- 1983-07-28 DD DD83253493A patent/DD209969A5/en not_active IP Right Cessation
- 1983-07-29 NO NO832756A patent/NO162365B/en not_active IP Right Cessation
- 1983-07-29 DK DK349583A patent/DK161867C/en not_active IP Right Cessation
- 1983-07-29 NZ NZ205084A patent/NZ205084A/en unknown
- 1983-07-29 KR KR1019830003545A patent/KR840005344A/en not_active Withdrawn
- 1983-07-29 PT PT77129A patent/PT77129B/en not_active IP Right Cessation
- 1983-07-29 PL PL24322783A patent/PL243227A1/en unknown
- 1983-07-29 NL NL8302709A patent/NL192916C/en not_active IP Right Cessation
- 1983-07-29 HU HU832717A patent/HU194731B/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5399349A (en) | Treatment of acne | |
| JPS6341364B2 (en) | ||
| KR20070064411A (en) | Topical Administration Carrier Compositions and Therapeutic Formulas Containing the Same | |
| NL8302709A (en) | HAIR REGROWTH. | |
| US3395236A (en) | Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections | |
| JP2001503405A (en) | Use of ginkgo flavonoid extracts substantially free of terpenes in the field of oral dentistry and compositions containing such extracts | |
| EP0305407B1 (en) | Use of dicarboxylic acids with 7-13 c atoms or their physiologically acceptable salts for the manufacture of a medicament for the topical treatment of acne rosacea | |
| US5637606A (en) | Hair grower based on allantoin or derivatives thereof | |
| JP2002332240A (en) | Hair restorer composition | |
| DE1492023C3 (en) | Skin care products | |
| JPS63313715A (en) | Hair growth stimulating composition | |
| JPH0455163B2 (en) | ||
| EP0117878B1 (en) | Product and method for the treatment of the hair | |
| Suzuki | Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants | |
| WO2018123960A1 (en) | Hair growth stimulant | |
| US20200022935A1 (en) | Topical formulation for treating bruising | |
| JPH05286836A (en) | Hair-raising cosmetic | |
| DE1617708A1 (en) | Cosmetic agent and method for making the same | |
| WO1995011035A1 (en) | Cosmetic preparation with anti-viral action for topical application | |
| JP2020075897A (en) | Cleaning agent for acne bacteria removal | |
| JPS61200919A (en) | External drug for skin | |
| FR2648351A1 (en) | USE OF GLYCOPROTEIC COMPLEXES EXTRACTED FROM GRAM (-) BACTERIA FOR THE MANUFACTURE OF A MEDICAMENT FOR FACILITATING THE HEALING OF THE SKIN AND PREPARATION METHOD | |
| HU195420B (en) | CREATED COSMETIC COMPOSITIONS FOR INCREASED REGENERATION AND / OR HYDRAULIC EFFECTS | |
| DE3010233A1 (en) | Prevention or removal of scar tissue with oleum hyoscyami - applied in a composition for topical application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| V1 | Lapsed because of non-payment of the annual fee |
Effective date: 20020201 Effective date: 20020201 |